300 related articles for article (PubMed ID: 27113016)
1. Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.
Baurley JW; Edlund CK; Pardamean CI; Conti DV; Krasnow R; Javitz HS; Hops H; Swan GE; Benowitz NL; Bergen AW
Nicotine Tob Res; 2016 Sep; 18(9):1837-1844. PubMed ID: 27113016
[TBL] [Abstract][Full Text] [Related]
2. Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.
Yuan JM; Nelson HH; Butler LM; Carmella SG; Wang R; Kuriger-Laber JK; Adams-Haduch J; Hecht SS; Gao YT; Murphy SE
Int J Cancer; 2016 May; 138(9):2161-71. PubMed ID: 26662855
[TBL] [Abstract][Full Text] [Related]
3. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
Tanner JA; Henderson JA; Buchwald D; Howard BV; Nez Henderson P; Tyndale RF
Pharmacogenet Genomics; 2017 May; 27(5):169-178. PubMed ID: 28181923
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence.
Hancock DB; Guo Y; Reginsson GW; Gaddis NC; Lutz SM; Sherva R; Loukola A; Minica CC; Markunas CA; Han Y; Young KA; Gudbjartsson DF; Gu F; McNeil DW; Qaiser B; Glasheen C; Olson S; Landi MT; Madden PAF; Farrer LA; Vink J; Saccone NL; Neale MC; Kranzler HR; McKay J; Hung RJ; Amos CI; Marazita ML; Boomsma DI; Baker TB; Gelernter J; Kaprio J; Caporaso NE; Thorgeirsson TE; Hokanson JE; Bierut LJ; Stefansson K; Johnson EO
Mol Psychiatry; 2018 Sep; 23(9):1911-1919. PubMed ID: 28972577
[TBL] [Abstract][Full Text] [Related]
5. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism.
Tanner JA; Zhu AZ; Claw KG; Prasad B; Korchina V; Hu J; Doddapaneni H; Muzny DM; Schuetz EG; Lerman C; Thummel KE; Scherer SE; Tyndale RF
Pharmacogenet Genomics; 2018 Jan; 28(1):7-16. PubMed ID: 29232328
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
Nakajima M; Fukami T; Yamanaka H; Higashi E; Sakai H; Yoshida R; Kwon JT; McLeod HL; Yokoi T
Clin Pharmacol Ther; 2006 Sep; 80(3):282-97. PubMed ID: 16952495
[TBL] [Abstract][Full Text] [Related]
7. Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk.
Patel YM; Park SL; Han Y; Wilkens LR; Bickeböller H; Rosenberger A; Caporaso N; Landi MT; Brüske I; Risch A; Wei Y; Christiani DC; Brennan P; Houlston R; McKay J; McLaughlin J; Hung R; Murphy S; Stram DO; Amos C; Le Marchand L
Cancer Res; 2016 Oct; 76(19):5768-5776. PubMed ID: 27488534
[TBL] [Abstract][Full Text] [Related]
8. Variation in trans-3'-hydroxycotinine glucuronidation does not alter the nicotine metabolite ratio or nicotine intake.
Zhu AZ; Zhou Q; Cox LS; Ahluwalia JS; Benowitz NL; Tyndale RF
PLoS One; 2013; 8(8):e70938. PubMed ID: 23936477
[TBL] [Abstract][Full Text] [Related]
9. Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms.
Bloom AJ; Baker TB; Chen LS; Breslau N; Hatsukami D; Bierut LJ; Goate A
Hum Mol Genet; 2014 Jan; 23(2):555-61. PubMed ID: 24045616
[TBL] [Abstract][Full Text] [Related]
10. The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans.
Bloom J; Hinrichs AL; Wang JC; von Weymarn LB; Kharasch ED; Bierut LJ; Goate A; Murphy SE
Pharmacogenet Genomics; 2011 Jul; 21(7):403-16. PubMed ID: 21597399
[TBL] [Abstract][Full Text] [Related]
11. CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.
Malaiyandi V; Goodz SD; Sellers EM; Tyndale RF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1812-9. PubMed ID: 17035386
[TBL] [Abstract][Full Text] [Related]
12. A novel duplication type of CYP2A6 gene in African-American population.
Fukami T; Nakajima M; Yamanaka H; Fukushima Y; McLeod HL; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):515-20. PubMed ID: 17267622
[TBL] [Abstract][Full Text] [Related]
13. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.
Fukami T; Nakajima M; Sakai H; McLeod HL; Yokoi T
Pharmacogenomics J; 2006; 6(6):401-12. PubMed ID: 16636685
[TBL] [Abstract][Full Text] [Related]
14. Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
Park SL; Murphy SE; Wilkens LR; Stram DO; Hecht SS; Le Marchand L
PLoS One; 2017; 12(5):e0178435. PubMed ID: 28542511
[TBL] [Abstract][Full Text] [Related]
15. Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity.
Fukami T; Nakajima M; Higashi E; Yamanaka H; Sakai H; McLeod HL; Yokoi T
Drug Metab Dispos; 2005 Aug; 33(8):1202-10. PubMed ID: 15900015
[TBL] [Abstract][Full Text] [Related]
16. Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6.
Bloom AJ; Harari O; Martinez M; Madden PA; Martin NG; Montgomery GW; Rice JP; Murphy SE; Bierut LJ; Goate A
Hum Mol Genet; 2012 Jul; 21(13):3050-62. PubMed ID: 22451501
[TBL] [Abstract][Full Text] [Related]
17. Ethnic differences in nicotine metabolic rate among New Zealanders.
Lea R; Benowitz N; Green M; Fowles J; Vishvanath A; Dickson S; Lea M; Woodward A; Chambers G; Phillips D
N Z Med J; 2005 Dec; 118(1227):U1773. PubMed ID: 16372023
[TBL] [Abstract][Full Text] [Related]
18. Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.
Nakajima M
Curr Opin Mol Ther; 2007 Dec; 9(6):538-44. PubMed ID: 18041664
[TBL] [Abstract][Full Text] [Related]
19. Gene-centric analysis of serum cotinine levels in African and European American populations.
Hamidovic A; Goodloe RJ; Bergen AW; Benowitz NL; Styn MA; Kasberger JL; Choquet H; Young TR; Meng Y; Palmer C; Pletcher M; Kertesz S; Hitsman B; Spring B; Jorgenson E
Neuropsychopharmacology; 2012 Mar; 37(4):968-74. PubMed ID: 22089314
[TBL] [Abstract][Full Text] [Related]
20. Nicotine metabolism and CYP2A6 activity in a population of black African descent: impact of gender and light smoking.
Mwenifumbo JC; Sellers EM; Tyndale RF
Drug Alcohol Depend; 2007 Jun; 89(1):24-33. PubMed ID: 17161559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
